Golub Capital BDC

GBDC · NASDAQ

$12.00−$0.01 (−0.08%)TodayMarket closed ·
Prev close $12.01

GBDC analyst rating

BuyConsensus of 4 analysts over the last 12 months. 100% rate it a buy.
  • Strong buy0
  • Buy4
  • Hold0
  • Underperform0
  • Sell0

12-month price target · 8 analysts

Average $13.90 (+15.8% upside)

Low
$13.13
Now
$12.00
High
$14.70

Upgrades and downgrades

The latest rating actions, newest first

GBDC analyst upgrades, downgrades and rating actions
FirmDateActionRating
Keefe, Bruyette & WoodsAug 5, 2026MaintainsOutperform
RBC CapitalMay 7, 2026MaintainsOutperform
RBC CapitalApr 17, 2026InitiatesOutperform
Wells FargoFeb 6, 2026MaintainsOverweight
Keefe, Bruyette & WoodsFeb 6, 2026MaintainsOutperform
Wells FargoJan 7, 2026UpgradeEqual-Weight → Overweight
Keefe, Bruyette & WoodsNov 21, 2025MaintainsOutperform

The case for and against

Updated Jul 17, 2024

Bull case

Golub Capital BDC is showing promising performance indicators, including an increase in NAV of 1.3% that was driven by operating earnings surpassing the dividend and net portfolio gains. The first quarter with the company’s new, lower base fee resulted in an improved operating ROE of 13.5%, while GBDC's unique management fee structure with low fees and operating expenses and solid shareholder protections demonstrate strong overall governance. Despite slight rise in riskier investments, the company’s portfolio quality remains high and its credit quality metrics are strong – reflecting GBDC's capable management even given potential fluctuation in the broader U.S. marketplace.

Bear case

Golub Capital BDC is facing significant challenges due to unpredictable earnings or potential losses, excessively leveraged balance sheets, and heightened market volatility, all of which significantly increase its risk of principal loss. The firm's total and net leverage rates have been high, while a slowdown in credit markets within the broader U.S economy indicates increased financial pressure. Additionally, any substantial weakening in economic expectations could adversely affect the company's risk expectations and stock valuations, while a myriad of identified risk factors, including potential credit write-downs, access to capital, interest rate volatility, and regulatory changes, further contribute to a negative outlook on the stock.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.